S. Gately

发表

The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer

M. Penichet, D. Besselsen, T. Hahn, 2011, BMC Cancer.

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.

S. Brem, S. Gately, G. Soff, 1995, The Journal of clinical investigation.

Identification of novel HDAC inhibitors through cell based screening and their evaluation as potential anticancer agents.

S. Gately, Tong Wang, Mario Sepúlveda, 2013, Bioorganic & medicinal chemistry letters.

Suramin inhibits glioma cell proliferationin vitro and in the brain

H. Engelhard, S. Brem, S. Gately, 2005, Journal of Neuro-Oncology.

Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin.

M. Stack, J. Enghild, H. Schnaper, 1996, Cancer research.

A diaminoantraquinone inhibitor of angiogenesis.

S. Brem, S. Gately, J. B. Jiang, 1994, The Journal of pharmacology and experimental therapeutics.

Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib

J. Trent, S. Gately, J. MacKeigan, 2014, Autophagy.

Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients.

S. Gately, 2019, Cancer treatment and research.

Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.

S. Brem, D. Zagzag, S. Gately, 1990, The American journal of pathology.

Angiogenesis and Invasiveness: Pharmacological Suppression of Neoplastic Spread of Malignant Cell in the Brain

S. Brem, D. Zagzag, S. Gately, 1992 .

Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo.

A. Paller, S. Gately, G. Soff, 1997, Cancer research.

A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease Progression

D. Stephan, R. Bowser, S. Gately, 2012, Neurology research international.

Synthesis of lipophilic sila derivatives of N-acetylcysteineamide, a cell permeating thiol

U. I. Zakai, S. Gately, Daryl Staveness, 2010 .

Synthesis of improved lysomotropic autophagy inhibitors.

S. Gately, J. MacKeigan, Tong Wang, 2015, Journal of medicinal chemistry.

Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.

H. Engelhard, S. Brem, S. Gately, 1994, Cancer research.

The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.

M. Stack, J. Enghild, O. Volpert, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Novel silicon-containing drugs derived from the indomethacin scaffold: Synthesis, characterization and evaluation of biological activity

S. Gately, Irina S. Toulokhonova, R. West, 2007 .

Statin immunolocalization in human brain tumors. Detection of noncycling cells using a novel marker of cell quiescence

S. Brem, S. Gately, H. Schipper, 1991, Cancer.

Novel therapeutics with enhanced biological activity generated by the strategic introduction of silicon isosteres into known drug scaffolds

S. Gately, R. West, 2007 .

Cells transfected with the basic fibroblast growth factor gene fused to a signal sequence are invasive in vitro and in situ in the brain.

S. Brem, M. Klagsbrun, S. Gately, 1995, Neurosurgery.

Combined effects of angiostatin and ionizing radiation in antitumour therapy

R. Weichselbaum, V. Sukhatme, D. Kufe, 1998, Nature.

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy.

S. Gately, William Li, Stephen Gately, 2004, Seminars in oncology.

Immunolocalization of basic fibroblast growth factor to the micro vasculature of human brain tumors

S. Brem, S. Gately, A. Tsanaclis, 1992, Cancer.

Antiangiogenic scheduling of lower dose cancer chemotherapy.

R. Kerbel, S. Gately, 2001, Cancer journal.

Tumor production of angiostatin is enhanced after exposure to TNF‐α

M. Stack, R. Weichselbaum, D. Kufe, 2002, International journal of cancer.

The potential role of basic fibroblast growth factor in the transformation of cultured primary human fetal astrocytes and the proliferation of human glioma (U-87) cells.

S. Brem, S. Gately, G. Soff, 1995, Neurosurgery.

Preclinical Investigation of Nanoparticle Albumin-Bound Paclitaxel as a Potential Treatment for Adrenocortical Cancer

G. Hostetter, K. Bussey, D. V. Von Hoff, 2012, Annals of surgery.

Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.

M. Stack, J. Enghild, S. Gately, 1999, The Biochemical journal.

The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin

M. Stack, J. Enghild, O. Volpert, 1997 .

The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis

S. Gately, 2004, Cancer and Metastasis Reviews.

Smooth Muscle Cell Expression of Type I Cyclic GMP – dependent Protein Kinase Is Suppressed by Continuous Exposure to Nit rovasodilators , Theophylline , Cyclic GMP , and Cyclic AMP

T. Lincoln, T. Cornwell, S. Gately, 2013 .

Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP.

T. Lincoln, T. Cornwell, S. Gately, 1997, The Journal of clinical investigation.

Targeting cyclooxygenase-2 for cancer prevention and treatment.

S. Gately, 2005, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis.

R. Kerbel, S. Gately, 2003, Progress in experimental tumor research.

Angiosuppressive and Antiproliferative Actions of Suramin: A Growth Factor Antagonist

H. Engelhard, S. Brem, S. Gately, 1993 .

Brief Concomitant Exposures to Angiostatin Potentiation of the Antitumor Effect of Ionizing Radiation by Updated

R. Weichselbaum, V. Sukhatme, D. Kufe, 2006 .

Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.

R. Weichselbaum, V. Sukhatme, D. Kufe, 1998, Cancer research.

Mice lackingserum paraoxonasearesusceptible toorganophosphate toxicityandatherosclerosis

R. Weichselbaum, V. Sukhatme, D. Kufe, 1998 .

β-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites

T. Dunckley, S. Gately, Tong Wang, 2011, PloS one.

Immunolocalization of basic fibroblast growth factor to the micro vasculature of human brain tumors

S. Brem, S. Gately, A. Tsanaclis, 1992, Cancer.

Angiosuppression of Brain Tumors by Depletion of Copper and Penicillamine

S. Brem, D. Zagzag, S. Gately, 1992 .